Profile
Sector:
HealthcareIndustry:
Diagnostics & ResearchCountry:
United StatesIPO:
11 August 2016Website:
http://www.medpace.comNext earnings report:
12 February 2025Last dividends:
N/ANext dividends:
N/APrice
after hours | 13 min agoDividend
Analysts recommendations
Institutional Ownership
MEDP Latest News
NEW YORK, NY / ACCESSWIRE / November 4, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Medpace Holdings, Inc. ("Medpace" or the "Company") (NASDAQ:MEDP). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
NEW YORK, NY / ACCESSWIRE / November 3, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ:MEDP). Investors who purchased Medpace securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/MEDP.
LOS ANGELES, CA / ACCESSWIRE / November 2, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ:MEDP) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
NEW YORK , Nov. 2, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Medpace Holdings, Inc. ("Medpace" or the "Company") (NASDAQ: MEDP). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
NEW YORK, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldenstein"), a preeminent national shareholder rights litigation firm, announces that it is investigating is investigating claims on behalf of investors of Medpace Holdings, Inc. ("Medpace" or the "Company") (NASDAQ: MEDP).
RADNOR, PA / ACCESSWIRE / November 1, 2024 / The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of Medpace Holdings, Inc. (NASDAQ:MEDP) ("Medpace"). On October 21, 2024, during after-market hours, Medpace reported its third quarter 2024 financial results and cut its revenue guidance for full-year 2024.
RADNOR, Pa. , Oct. 30, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of Medpace Holdings, Inc. (NASDAQ: MEDP) ("Medpace").
NEW YORK, NY / ACCESSWIRE / October 28, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ:MEDP). Investors who purchased Medpace securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/MEDP.
LOS ANGELES, CA / ACCESSWIRE / October 27, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ:MEDP) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
NEW YORK, NY / ACCESSWIRE / October 27, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Medpace Holdings, Inc. ("Medpace" or the "Company") (NASDAQ:MEDP). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
What type of business is Medpace Holdings?
Medpace Holdings, Inc. specializes in conducting contract clinical research for companies in the biotechnology, pharmaceutical, and medical industries. It was founded in 1992. The headquarters is located in Cincinnati, Ohio (USA). Medpace Holdings, Inc. provides a wide range of services: monitoring clinical trials, laboratory analysis, electronic data capture, patient recruitment, and more. The company conducts scientific research on new drugs and medical devices in key therapeutic areas such as cardiology, hematology, oncology, neurology and psychiatry, vaccine development, antibiotics, etc. Clients of Medpace Holdings, Inc. include many leading global pharmaceutical, biotechnology companies, and medical device manufacturers.
What sector is Medpace Holdings in?
Medpace Holdings is in the Healthcare sector
What industry is Medpace Holdings in?
Medpace Holdings is in the Diagnostics & Research industry
What country is Medpace Holdings from?
Medpace Holdings is headquartered in United States
When did Medpace Holdings go public?
Medpace Holdings initial public offering (IPO) was on 11 August 2016
What is Medpace Holdings website?
https://www.medpace.com
Is Medpace Holdings in the S&P 500?
No, Medpace Holdings is not included in the S&P 500 index
Is Medpace Holdings in the NASDAQ 100?
No, Medpace Holdings is not included in the NASDAQ 100 index
Is Medpace Holdings in the Dow Jones?
No, Medpace Holdings is not included in the Dow Jones index
When was Medpace Holdings the previous earnings report?
No data
When does Medpace Holdings earnings report?
The next expected earnings date for Medpace Holdings is 12 February 2025